Debunking GLP-1 Myths: The Truth About Medical Weight Loss
The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
Typically, compounded drugs are made for patients who aren't served by existing FDA-approved medicines
In addition, procedures that remove excess skin, like body lift, tummy tuck, and breast lift, are most effective when a patient is near their ideal weight, so their surgeon can remove a more significant amount of excess skin and tighten the remaining tissue
Uh, the other thing is that I think we just need to say that, you know, these are not for everyone
CrossRef Ferroptosis modulation by METTL14 in cancers: From molecular insights to therapeutic strategies Boran Huang, Chenglin Zhu, Xinyu Zhang, Qi Zhang, Honggang Wang Cellular Signalling .2026
